Daniel Adelman, MD


Pulmonary, Critical Care, Allergy and Sleep Medicine

M.D., 1983 - School of Medicine, University of California Davis
  1. Calise J, DeBerg H, Garabatos N, Khosa S, Bajzik V, Calderon LB, Aldridge K, Rosasco M, Ferslew BC, Zhu T, Smulders R, Wheatley LM, Laidlaw TM, Qin T, Chichili GR, Adelman DC, Farrington M, Robinson D, Jeong D, Jones SM, Sanda S, Larson D, Kwok WW, Baloh C, Nepom GT, Wambre E, IMPACT. Distinct trajectories distinguish antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy. The Journal of allergy and clinical immunology 2023. PMID: 37003475

  2. Ciaccio C, Goldsobel AB, Anagnostou A, Beyer K, Casale TB, Deschildre A, Fern?ndez-Rivas M, Hourihane JO, Krawiec M, Lieberman J, Scurlock AM, Vickery BP, Smith A, Tilles SA, Adelman DC, Brown KR, RAMSES (ARC007) and ARC011 Study Groups:. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2022. PMID: 35973655

  3. Baker J, Beyer K, du Toit G, Shreffler W, Brown KR, Norval D, Vereda A, Adelman D, Jones SM, Burks W, Casale T. Reply. 2022. PMID: 35491264

  4. Chinthrajah RS, Jones SM, Kim EH, Sicherer SH, Shreffler W, Lanser BJ, Atri N, Babineau DC, Adelman DC, Iqbal A, Limb SL, Rudman Spergel AK, Togias A, Wood RA. Updating the CoFAR Grading Scale for Systemic Allergic Reactions in Food Allergy. 2022. PMID: 35026206

  5. Brown KR, Baker J, Vereda A, Beyer K, Burks AW, du Toit G, O'B Hourihane J, Jones SM, Norval D, Dana A, Shreffler W, Vickery BP, Casale T, Skeel B, Adelman D. Safety of Peanut (Arachis hypogaea) Allergen Powder-dnfp in Children and Teenagers With Peanut Allergy: A Pooled Summary of Phase 3 and Extension Trials. 2021. PMID: 34971646

  6. Nilsson C, Scurlock AM, Dellon ES, Brostoff JM, Pham T, Ryan R, Brown KR, Adelman DC, Aceves SS. Onset of eosinophilic esophagitis during a clinical trial program of oral immunotherapy for peanut allergy. The journal of allergy and clinical immunology. In practice 2021. PMID: 34389504

  7. Patel N, Adelman DC, Anagnostou K, Baumert JL, Blom WM, Campbell DE, Chinthrajah RS, Mills ENC, Javed B, Purington N, Remington BC, Sampson HA, Smith AD, Yarham RAR, Turner PJ. Using data from food challenges to inform management of consumers with food allergy: A systematic review with individual participant data meta-analysis. The Journal of allergy and clinical immunology 2021. PMID: 33571537

  8. Vickery BP, Vereda A, Nilsson C, du Toit G, Shreffler WG, Burks AW, Jones SM, Fernández-Rivas M, Blümchen K, O'B Hourihane J, Beyer K, Smith A, Ryan R, Adelman DC. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study. The journal of allergy and clinical immunology. In practice 2020. PMID: 33359589

  9. Hourihane JO, Beyer K, Abbas A, Fernández-Rivas M, Turner PJ, Blumchen K, Nilsson C, Ibáñez MD, Deschildre A, Muraro A, Sharma V, Erlewyn-Lajeunesse M, Zubeldia JM, De Blay F, Sauvage CD, Byrne A, Chapman J, Boralevi F, DunnGalvin A, O'Neill C, Norval D, Vereda A, Skeel B, Adelman DC, du Toit G. Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. The Lancet. Child & adolescent health 2020. PMID: 32702315

  10. Syage JA, Green PHR, Khosla C, Adelman DC, Sealey-Voyksner JA, Murray JA. Latiglutenase Treatment for Celiac Disease: Symptom and Quality of Life Improvement for Seropositive Patients on a Gluten-Free Diet. Volume 1 of Issue 6. GastroHep 2019. PMID: 32313451

  11. Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibáñez MD, Tilles S, Assa’ad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernández-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW. AR101 Oral Immunotherapy for Peanut Allergy. Volume 379 of Issue 21. The New England journal of medicine 2018. PMID: 30449234

  12. Adelman DC, Murray J, Wu TT, Mäki M, Green PH, Kelly CP. Measuring Change In Small Intestinal Histology In Patients With Celiac Disease. Volume 113 of Issue 3. The American journal of gastroenterology 2018. PMID: 29460921

  13. Mahadev S, Murray JA, Wu TT, Chandan VS, Torbenson MS, Kelly CP, Maki M, Green PH, Adelman D, Lebwohl B. Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet. Volume 45 of Issue 8. Alimentary pharmacology & therapeutics 2017. PMID: 28220520

  14. Leffler DA, Acaster S, Gallop K, Dennis M, Kelly CP, Adelman DC. A Novel Patient-Derived Conceptual Model of the Impact of Celiac Disease in Adults: Implications for Patient-Reported Outcome and Health-Related Quality-of-Life Instrument Development. Volume 20 of Issue 4. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2017. PMID: 28408006

  15. Garber ME, Saldanha A, Parker JS, Jones WD, Kaukinen K, Laurila K, Lähdeaho ML, Khatri P, Khosla C, Adelman DC, Mäki M. A B-Cell Gene Signature Correlates With the Extent of Gluten-Induced Intestinal Injury in Celiac Disease. Volume 4 of Issue 1. Cellular and molecular gastroenterology and hepatology 2017. PMID: 28508029

  16. Murray JA, Kelly CP, Green PHR, Marcantonio A, Wu TT, Mäki M, Adelman DC. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease. Volume 152 of Issue 4. Gastroenterology 2016. PMID: 27864127

  17. Adelman DC, Howard K. Assessing Quality of Life in Patients with Common Variable Immunodeficiency: Why It Matters. Volume 4 of Issue 6. The journal of allergy and clinical immunology. In practice 2016. PMID: 27836063

  18. Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Volume 146 of Issue 7. Gastroenterology 2014. PMID: 24583059

  19. Corren J, Shapiro G, Reimann J, Deniz Y, Wong D, Adelman D, Togias A. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy. Volume 121 of Issue 2. The Journal of allergy and clinical immunology 2008. PMID: 18269927

  20. Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D, Davancaze T, Adelman D. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis. Volume 93 of Issue 3. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004. PMID: 15478383

  21. Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC. Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. Circulation 2003. PMID: 12939212

  22. Chen Z, Woodburn KW, Shi C, Adelman DC, Rogers C, Simon DI. Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells. Volume 21 of Issue 5. Arteriosclerosis, thrombosis, and vascular biology 2001. PMID: 11348871

  23. Rockson SG, Kramer P, Razavi M, Szuba A, Filardo S, Fitzgerald P, Cooke JP, Yousuf S, DeVault AR, Renschler MF, Adelman DC. Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin). Volume 102 of Issue 19. Circulation 2000. PMID: 11067782

  24. Shearer WT, Abramson SL, Adelman DC, Corn B, Cunningham-Rundles C, Kishiyama JL, Richmond W, Shames RS, Sperber K, Stiehm ER, Valacer DJ. Letter to the editor regarding the use of intravenous immunoglobulin (IVIG) in asthma. Volume 93 of Issue 2. Clinical immunology (Orlando, Fla.) 1999. PMID: 10527695

  25. Fahy JV, Cockcroft DW, Boulet LP, Wong HH, Deschesnes F, Davis EE, Ruppel J, Su JQ, Adelman DC. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. American journal of respiratory and critical care medicine 1999. PMID: 10471635

  26. Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Volume 91 of Issue 2. Clinical immunology (Orlando, Fla.) 1999. PMID: 10227804

  27. Shames RS, Heilbron DC, Janson SL, Kishiyama JL, Au DS, Adelman DC. Clinical differences among women with and without self-reported perimenstrual asthma. Volume 81 of Issue 1. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1998. PMID: 9690575

  28. Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB, Adelman DC. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. Volume 100 of Issue 1. The Journal of allergy and clinical immunology 1997. PMID: 9257795

  29. MacGlashan DW, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. Volume 158 of Issue 3. Journal of immunology (Baltimore, Md. : 1950) 1997. PMID: 9013989

  30. Shanafelt MC, Yssel H, Soderberg C, Steinman L, Adelman DC, Peltz G, Lahesmaa R. CD45 isoforms on human CD4+ T-cell subsets. Volume 98 of Issue 2. The Journal of allergy and clinical immunology 1996. PMID: 8757221

  31. Adelman DC. Genetic basis of the primary immunodeficiency syndromes. Volume 163 of Issue 4. The Western journal of medicine 1995. PMID: 7483602

  32. Shearer WT, Adelman DC, Huston DP, Engler RJ, Gupta S, Ledford DK, Lopez M, Du Buske LM. Core content outline for clinical and laboratory immunology. AAAI Training Program Directors' Committee. Volume 94 of Issue 6 Pt 1. The Journal of allergy and clinical immunology 1994. PMID: 7798541

  33. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of beta-lactam antibiotics. Volume 10 of Issue 4. Drug safety 1994. PMID: 8018304

  34. Hassner A, Lau MS, Goetzl EJ, Adelman DC. Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. Volume 92 of Issue 6. The Journal of allergy and clinical immunology 1993. PMID: 8258623

  35. Adelman DC, Yen TY, Cumberland WG, Sidell N, Saxon A. 13-cis retinoic acid enhances in vivo B-lymphocyte differentiation in patients with common variable immunodeficiency. Volume 88 of Issue 5. The Journal of allergy and clinical immunology 1991. PMID: 1720149

  36. Hassner A, Adelman DC. Biologic response modifiers in primary immunodeficiency disorders. Volume 115 of Issue 4. Annals of internal medicine 1991. PMID: 1854114

  37. Adelman D. Penicillin allergy. Volume 154 of Issue 4. The Western journal of medicine 1991. PMID: 1877185

  38. Goetzl EJ, Hassner A, Cheng PP, Robichon A, Adelman DC, Sreedharan SP. Molecular characteristics of the cellular receptor for vasoactive intestinal peptide. Volume 104. Transactions of the Association of American Physicians 1991. PMID: 1668991

  39. Goetzl EJ, Cheng PP, Hassner A, Adelman DC, Frick OL, Sreedharan SP. Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Volume 20 Suppl 4. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 1990. PMID: 2282540

  40. Adelman DC, Matsuda T, Hirano T, Kishimoto T, Saxon A. Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency. Volume 86 of Issue 4 Pt 1. The Journal of allergy and clinical immunology 1990. PMID: 2229813

  41. Goetzl EJ, Adelman DC, Sreedharan SP. Neuroimmunology. Volume 48. Advances in immunology 1990. PMID: 1971989

  42. Adelman DC, Spector SL. Acute respiratory emergencies in emergency treatment of the injured athlete. Volume 8 of Issue 1. Clinics in sports medicine 1989. PMID: 2663179

  43. Best CL, Walters C, Adelman DC. Fixed cutaneous eruptions to seminal-plasma challenge: a case report. Volume 50 of Issue 3. Fertility and sterility 1988. PMID: 3410107

  44. Saxon A, Adelman DC, Patel A, Hajdu R, Calandra GB. Imipenem cross-reactivity with penicillin in humans. Volume 82 of Issue 2. The Journal of allergy and clinical immunology 1988. PMID: 2457043

  45. Sherr E, Adelman DC, Saxon A, Gilly M, Wall R, Sidell N. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency. Volume 168 of Issue 1. The Journal of experimental medicine 1988. PMID: 3294336

  46. Adelman DC, Saxon A. Recurrent bacterial infections and cellulitis in a 29-year-old woman with a history of hypogammaglobulinemia. Volume 59 of Issue 6. Annals of allergy 1987. PMID: 3425979

  47. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Volume 107 of Issue 2. Annals of internal medicine 1987. PMID: 3300459